
The Trajectory of AI in Drug Discovery: Targeting Bacterial Pathogens
A new computational pipeline uses machine learning and deep learning to identify uncharacterised protein targets in Chlamydia pneumoniae. While still early-stage and awaiting peer review, this method points toward a faster, data-driven future for antimicrobial research.
By Dutta

